These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11926127)

  • 1. Recombinant antibodies for the selective targeting of tumor neovasculature.
    Viti F; Giovannoni L; Neri D
    Curr Opin Drug Discov Devel; 2002 Mar; 5(2):204-13. PubMed ID: 11926127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-Based targeting of angiogenesis.
    Halin C; Neri D
    Crit Rev Ther Drug Carrier Syst; 2001; 18(3):299-339. PubMed ID: 11442202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer immunotherapy of targeting angiogenesis.
    Hou J; Tian L; Wei Y
    Cell Mol Immunol; 2004 Jun; 1(3):161-6. PubMed ID: 16219162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective targeting and photocoagulation of ocular angiogenesis mediated by a phage-derived human antibody fragment.
    Birchler M; Viti F; Zardi L; Spiess B; Neri D
    Nat Biotechnol; 1999 Oct; 17(10):984-8. PubMed ID: 10504699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies for angiogenesis inhibition, vascular targeting and endothelial cell transcytosis.
    Trachsel E; Neri D
    Adv Drug Deliv Rev; 2006 Aug; 58(5-6):735-54. PubMed ID: 16822576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-angiogenic gene therapy for cancer (review).
    Isayeva T; Kumar S; Ponnazhagan S
    Int J Oncol; 2004 Aug; 25(2):335-43. PubMed ID: 15254730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-based targeting of angiogenesis.
    Halin C; Zardi L; Neri D
    News Physiol Sci; 2001 Aug; 16():191-4. PubMed ID: 11479371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting angiogenesis with antibodies for the treatment of cancer.
    Andreasson P; Carlsson R
    IDrugs; 2005 Sep; 8(9):730-3. PubMed ID: 16118694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2 in cancer and angiogenesis.
    Sahin M; Sahin E; Gümüslü S
    Angiology; 2009; 60(2):242-53. PubMed ID: 18505747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Targeting blood vessels for treatment of cancer...].
    Sonveaux P; Feron O
    J Pharm Belg; 2003; 58(3):79-80. PubMed ID: 14619689
    [No Abstract]   [Full Text] [Related]  

  • 11. Structure of solid tumors and their vasculature: implications for therapy with monoclonal antibodies.
    Dvorak HF; Nagy JA; Dvorak AM
    Cancer Cells; 1991 Mar; 3(3):77-85. PubMed ID: 1711364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth.
    Laakkonen P; Waltari M; Holopainen T; Takahashi T; Pytowski B; Steiner P; Hicklin D; Persaud K; Tonra JR; Witte L; Alitalo K
    Cancer Res; 2007 Jan; 67(2):593-9. PubMed ID: 17234768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor endothelial cells are targets for selective therapies: in vitro and in vivo models to evaluate antiangiogenic strategies.
    Dutour A; Rigaud M
    Anticancer Res; 2005; 25(6B):3799-807. PubMed ID: 16309166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target therapy of cancer: implementation of monoclonal antibodies and nanobodies.
    Majidi J; Barar J; Baradaran B; Abdolalizadeh J; Omidi Y
    Hum Antibodies; 2009; 18(3):81-100. PubMed ID: 19729803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor angiogenesis--a potential target in cancer chemoprevention.
    Bhat TA; Singh RP
    Food Chem Toxicol; 2008 Apr; 46(4):1334-45. PubMed ID: 17919802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The extra-domain A of fibronectin is a vascular marker of solid tumors and metastases.
    Rybak JN; Roesli C; Kaspar M; Villa A; Neri D
    Cancer Res; 2007 Nov; 67(22):10948-57. PubMed ID: 18006840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Y-labeled nanoparticles.
    Li L; Wartchow CA; Danthi SN; Shen Z; Dechene N; Pease J; Choi HS; Doede T; Chu P; Ning S; Lee DY; Bednarski MD; Knox SJ
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1215-27. PubMed ID: 15001266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and therapeutic applications of recombinant antibodies: targeting the extra-domain B of fibronectin, a marker of tumor angiogenesis.
    Ebbinghaus C; Scheuermann J; Neri D; Elia G
    Curr Pharm Des; 2004; 10(13):1537-49. PubMed ID: 15134574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered affinity proteins for tumour-targeting applications.
    Friedman M; Ståhl S
    Biotechnol Appl Biochem; 2009 May; 53(Pt 1):1-29. PubMed ID: 19341363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
    Pradeep CR; Sunila ES; Kuttan G
    Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.